All Press Releases

ALL PRESS RELEASES 2018
Nov 30, 2018
Modus Therapeutics Announces FDA Acceptance Of Sevuparin IND For Treatment Of Sickle Cell Disease >
Jul 13, 2018
Modus Therapeutics Completes A SEK 140m Financing Led By HealthCap >
Apr 18, 2018
Sevuparin Receives Rare Pediatric Disease Designation From FDA For The Treatment Of Children With Sickle Cell Disease >
Mar 23, 2018
Notice Of Extraordinary General Meeting In Modus Therapeutics Holding AB (Publ) >
Mar 15, 2018
Dr. John Öhd Appointed Chief Medical Officer At Modus Therapeutics >